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A 59-year-old man presented to our offi ce with progressive dysphonia, dysphagia, and inability to breathe while sleeping on his left side. His history included a Tefl on injection to the right vocal fold more than a decade earlier. Flexible transnasal laryngoscopy (fi gure 1, A and video) and rigid transoral stroboscopy (fi gure 1, B and video) revealed the presence of a large erythematous mass that encompassed the right musculomembranous vocal fold.
Computed tomography (CT) demonstrated a wellcircumscribed, 1.6 × 1-cm high-density mass encompassing the right vocal fold (fi gure 2). Th e patient was diagnosed with an expanding Tefl on granuloma, and he was taken to the operating room for a partial CO 2 laser excision of the lesion. Aft er surgery, his dysphagia and dyspnea resolved, although moderate dysphonia persisted.
A
Tefl on (polytetrafl uoroethylene) was introduced in 1962 to augment the vocal folds and improve aspiration and dysphonia secondary to glottic insuffi ciency. 1 It remained the mainstay of treatment for these conditions for more than 25 years, until delayed complications from granuloma formation became evident. 1 According to some authors, polytetrafl uoroethylene granulomas can be misinterpreted as cancerous tumors on CT and even on positron-emission tomography. 2, 3 It is important to recognize Tefl on granulomas because the population aff ected by this complication is growing. It is probable that more patients suff ering from this condition will present to otolaryngologists with a diverse array of head and neck symptoms that may mimic other diseases. 
